XML 60 R45.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2018
Income Tax Disclosure [Abstract]  
Schedule of income from continuing operations before income taxes
 
Years Ended March 31,
(In millions)
2018
 
2017
 
2016
Income from continuing operations before income taxes
 
 
 
 
 
U.S.
$
1,175

 
$
5,772

 
$
2,319

Foreign
(936
)
 
1,119

 
931

Total income from continuing operations before income taxes
$
239

 
$
6,891

 
$
3,250

Schedule of income tax expense related to continuing operations
Income tax expense related to continuing operations consists of the following:
 
Years Ended March 31,
(In millions)
2018
 
2017
 
2016
Current
 
 
 
 
 
Federal
$
577

 
$
524

 
$
658

State
33

 
86

 
96

Foreign
205

 
122

 
90

Total current
815

 
732

 
844

 
 
 
 
 
 
Deferred
 
 
 
 
 
Federal
(767
)
 
767

 
95

State
17

 
164

 
42

Foreign
(118
)
 
(49
)
 
(73
)
Total deferred
(868
)
 
882

 
64

Income tax (benefit) expense
$
(53
)
 
$
1,614

 
$
908

Schedule of reconciliation between effective tax rate on income from continuing operations and statutory tax rate
The reconciliation of income tax expense (benefit) and the amount computed by applying the statutory federal income tax rate of 31.6% for 2018 and 35% for 2017 and 2016 to the income before income taxes is as follows:
 
Years Ended March 31,
(In millions)
2018
 
2017
 
2016
Income tax expense at federal statutory rate
$
75

 
$
2,411

 
$
1,137

State income taxes net of federal tax benefit
50

 
153

 
92

Tax effect of foreign operations
(146
)
 
(326
)
 
(295
)
Unrecognized tax benefits and settlements
454

 
57

 
(14
)
Non-deductible goodwill
585

 
106

 

Share-based compensation
(8
)
 
(54
)
 

Net tax benefit on intellectual property transfer
(178
)
 
(137
)
 

Rate differential on gain from Change Healthcare Net Asset Exchange

 
(587
)
 

Remeasurement of U.S. deferred taxes
(1,324
)
 

 

Transition tax on foreign earnings
457

 

 

Other, net (1)
(18
)
 
(9
)
 
(12
)
Income tax (benefit) expense
$
(53
)
 
$
1,614

 
$
908


(1)
Our 2018 effective tax rate was impacted by other favorable U.S. federal permanent differences including research and development credits of $11 million.

Schedule of deferred tax balances
Deferred tax balances consisted of the following:
 
March 31,
(In millions)
2018
 
2017
Assets
 
 
 
Receivable allowances
$
58

 
$
124

Compensation and benefit related accruals
345

 
593

Net operating loss and credit carryforwards
811

 
594

Long-term contractual obligations
59

 
107

Other
279

 
241

Subtotal
1,552

 
1,659

Less: valuation allowance
(751
)
 
(503
)
Total assets
801

 
1,156

Liabilities
 
 
 
Inventory valuation and other assets
(1,869
)
 
(2,818
)
Fixed assets and systems development costs
(158
)
 
(224
)
Intangibles
(644
)
 
(921
)
Change Healthcare Equity Investment
(814
)
 
(773
)
Other
(71
)
 
(70
)
Total liabilities
(3,556
)
 
(4,806
)
Net deferred tax liability
$
(2,755
)
 
$
(3,650
)
 
 
 
 
Long-term deferred tax asset
49

 
28

Long-term deferred tax liability
(2,804
)
 
(3,678
)
Net deferred tax liability
$
(2,755
)
 
$
(3,650
)

Schedule of gross unrecognized tax benefits
The following table summarizes the activity related to our gross unrecognized tax benefits for the last three years:
 
Years Ended March 31,
(In millions)
2018
 
2017
 
2016
Unrecognized tax benefits at beginning of period
$
486

 
$
555

 
$
616

Additions based on tax positions related to prior years
47

 
7

 
116

Reductions based on tax positions related to prior years
(124
)
 
(67
)
 
(62
)
Additions based on tax positions related to current year
778

 
105

 
28

Reductions based on settlements
(7
)
 
(113
)
 
(141
)
Reductions based on the lapse of the applicable statutes of limitations

 

 
(6
)
Exchange rate fluctuations
3

 
(1
)
 
4

Unrecognized tax benefits at end of period
$
1,183

 
$
486

 
$
555